Literature DB >> 22520791

Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study.

Miren I Jones1, Sheila M Greenfield, Emma P Bray, Sabrina Baral-Grant, F D Richard Hobbs, Roger Holder, Paul Little, Jonathan Mant, Satnam K Virdee, Bryan Williams, Richard J McManus.   

Abstract

BACKGROUND: Self-management of hypertension, comprising self-monitoring of blood pressure with self-titration of medication, improves blood pressure control, but little is known regarding the views of patients undertaking it. AIM: To explore patients' views of self-monitoring blood pressure and self-titration of antihypertensive medication. DESIGN AND
SETTING: Qualitative study embedded within the randomised controlled trial TASMINH2 (Telemonitoirng and Self Management in the Control of Hypertension) trial of patient self-management of hypertension from 24 general practices in the West Midlands.
METHOD: Taped and transcribed semi-structured interviews with 23 intervention patients were used. Six family members were also interviewed. Analysis was by a constant comparative method.
RESULTS: Patients were confident about self-monitoring and many felt their multiple home readings were more valid than single office readings taken by their GP. Although many patients self-titrated medication when required, others lacked the confidence to increase medication without reconsulting with their GP. Patients were more comfortable with titrating medication if their blood pressure readings were substantially above target, but were reluctant to implement such a change if readings were borderline. Many planned to continue self-monitoring after the study finished and report home readings to their GP, but few wished to continue with a self-management plan.
CONCLUSION: Participants valued the additional information and many felt confident in both self-monitoring blood pressure and self-titrating medication. The reluctance to change medication for borderline readings suggests behaviour similar to the clinical inertia seen for physicians in analogous circumstances. Additional support for those lacking in confidence to implement prearranged medication changes may allow more patients to undertake self-management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520791      PMCID: PMC3268493          DOI: 10.3399/bjgp12X625201

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  22 in total

1.  Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials.

Authors:  Emma P Bray; Roger Holder; Jonathan Mant; Richard J McManus
Journal:  Ann Med       Date:  2010-07       Impact factor: 4.709

2.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

3.  Grounded theory, mixed methods, and action research.

Authors:  Lorelei Lingard; Mathieu Albert; Wendy Levinson
Journal:  BMJ       Date:  2008-08-07

Review 4.  Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

5.  Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial.

Authors:  Beverly B Green; Andrea J Cook; James D Ralston; Paul A Fishman; Sheryl L Catz; James Carlson; David Carrell; Lynda Tyll; Eric B Larson; Robert S Thompson
Journal:  JAMA       Date:  2008-06-25       Impact factor: 56.272

6.  Continued improvement in hypertension management in England: results from the Health Survey for England 2006.

Authors:  Emanuela Falaschetti; Moushumi Chaudhury; Jennifer Mindell; Neil Poulter
Journal:  Hypertension       Date:  2009-02-09       Impact factor: 10.190

7.  An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment.

Authors:  Andreas Zeller; Knut Schroeder; Tim J Peters
Journal:  J Clin Epidemiol       Date:  2007-08-23       Impact factor: 6.437

8.  Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Authors:  A J Farmer; A N Wade; D P French; J Simon; P Yudkin; A Gray; A Craven; L Goyder; R R Holman; D Mant; A-L Kinmonth; H A W Neil
Journal:  Health Technol Assess       Date:  2009-02       Impact factor: 4.014

9.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Peter S Sever; Neil R Poulter
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

10.  Barriers to optimal hypertension control.

Authors:  Gbenga Ogedegbe
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

View more
  47 in total

1.  SMS-facilitated home blood pressure monitoring: A qualitative analysis of resultant health behavior change.

Authors:  Matthew E Allen; Taya Irizarry; Julian Einhorn; Thomas W Kamarck; Brian P Suffoletto; Lora E Burke; Bruce L Rollman; Matthew F Muldoon
Journal:  Patient Educ Couns       Date:  2019-06-17

2.  Experiences of front-line health professionals in the delivery of telehealth: a qualitative study.

Authors:  Virginia MacNeill; Caroline Sanders; Ray Fitzpatrick; Jane Hendy; James Barlow; Martin Knapp; Anne Rogers; Martin Bardsley; Stanton P Newman
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

3.  Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England.

Authors:  Natasha Mejzner; Christopher E Clark; Lindsay Fp Smith; John L Campbell
Journal:  Br J Gen Pract       Date:  2017-03-27       Impact factor: 5.386

4.  Performance and persistence of a blood pressure self-management intervention: telemonitoring and self-management in hypertension (TASMINH2) trial.

Authors:  E P Bray; M I Jones; M Banting; S Greenfield; F D R Hobbs; P Little; B Williams; R J Mcmanus
Journal:  J Hum Hypertens       Date:  2015-01-08       Impact factor: 3.012

5.  Self-monitoring blood pressure in patients with hypertension: an internet-based survey of UK GPs.

Authors:  Benjamin R Fletcher; Lisa Hinton; Emma P Bray; Andrew Hayen; Fd Richard Hobbs; Jonathan Mant; John F Potter; Richard J McManus
Journal:  Br J Gen Pract       Date:  2016-08-30       Impact factor: 5.386

6.  Implementing home blood glucose and blood pressure telemonitoring in primary care practices for patients with diabetes: lessons learned.

Authors:  Richelle J Koopman; Bonnie J Wakefield; Jennifer L Johanning; Lynn E Keplinger; Robin L Kruse; Marilee Bomar; Beth Bernt; Douglas S Wakefield; David R Mehr
Journal:  Telemed J E Health       Date:  2013-12-18       Impact factor: 3.536

7.  Patients' preference for ambulatory versus home blood pressure monitoring.

Authors:  E G Nasothimiou; N Karpettas; M G Dafni; G S Stergiou
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

8.  Self-monitoring in hypertension: a web-based survey of primary care physicians.

Authors:  R J McManus; S Wood; E P Bray; P Glasziou; A Hayen; C Heneghan; J Mant; P Padfield; J F Potter; F D R Hobbs
Journal:  J Hum Hypertens       Date:  2013-07-04       Impact factor: 3.012

9.  Development of a novel tool for engaging children and parents in asthma self-management.

Authors:  Flory L Nkoy; Bryan L Stone; Bernhard A Fassl; Karmella Koopmeiners; Sarah Halbern; Eun H Kim; Justin Poll; Joseph W Hales; Dillon Lee; Christopher G Maloney
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

Review 10.  Using digital interventions for self-management of chronic physical health conditions: A meta-ethnography review of published studies.

Authors:  Katherine Morton; Laura Dennison; Carl May; Elizabeth Murray; Paul Little; Richard J McManus; Lucy Yardley
Journal:  Patient Educ Couns       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.